Fu Ming-Hai, Yu Hong-Zhen, Bao Te-Ri-Ge-le, Ba Gen-Na
National Medical Products Administration Key Laboratory for Quality Control of Traditional Chinese Medicine(Mongolian Medicine), Inner Mongolia University for Nationalities Tongliao 028000, China School of Mongolian Medicine, Inner Mongolia University for Nationalities Tongliao 028000, China.
National Medical Products Administration Key Laboratory for Quality Control of Traditional Chinese Medicine(Mongolian Medicine), Inner Mongolia University for Nationalities Tongliao 028000, China.
Zhongguo Zhong Yao Za Zhi. 2022 Jun;47(11):3049-3058. doi: 10.19540/j.cnki.cjcmm.20211125.701.
This study aims to explore anti-obesity and lipid-lowering mechanism of Corydalis Bungeanae Herba(CB) based on intestinal microflora and metabolomics. Specifically, high-fat high-sugar diet(HFHS, 10 weeks) was used to induce obesity in rats. Then the model rats were randomized into the model group, low-dose(0.18 g·kg(-1)), medium-dose(0.9 g·kg(-1)), and high-dose(1.8 g·kg(-1)) CBH groups, and orlistat group(0.03 g·kg(-1)), 12 in each group. Rats which received normal diet were used as control. The body weight and feed intake of rats were recorded every week. After 6 weeks of administration, rats were killed and gastric emptying and small intestinal propulsion were examined. Enzyme-linked immunosorbent assay(ELISA) was employed to analyze serum indexes, and liver and perirenal fat were collected for haematoxilin-eosin(HE) staining. Rat feces and serum were gathered for 16 S rDNA sequencing and metabolomics analysis and Spearman's correlation analysis was performed to explore the correlation between differential microflora and differential metabolites. The result showed that CBH extract decreased body weight, feed intake, and serum cholecystokinin(CCK), triglyceride(TG), and total cholesterol(TC), delayed gastric emptying, and reduced fat accumulation in liver and perirenal adiposity as compared with rats in the model group. In addition, Lachnospiraceae and Sutterellaceaecan significantly decreased in the model group, but CBH extract up-regulated their abundance. Moreover, the abundance of Prevotellaceae was significantly raised by HFHS, but CBH decreased it. Glutaric acid, glyceric acid, hippuric acid, malic acid, glyceric acid, oxoglutaric acid, fumaric acid/succinic acid, oxoglutaric acid/isocitric acid, D-glucuronic acid, cholic acid were the main deferentially expressed metabolites and significantly correlated with Sutterellaceae and Prevotellaceae. These key metabolites and microbiota mainly involved in tricarboxylic acid(TCA) cycle, glucose metabolism, amino acid metabolism, and energy metabolism. This study proved that CBH can efficiently improve body weight and blood lipids, reduce adipocyte volume, and positively regulate the intestinal microflora and serum metabolites, thereby achieving the anti-obesity and lipid-owering effect.
本研究旨在基于肠道微生物群和代谢组学探讨地丁草(CB)的抗肥胖和降脂机制。具体而言,采用高脂高糖饮食(HFHS,10周)诱导大鼠肥胖。然后将模型大鼠随机分为模型组、低剂量(0.18 g·kg⁻¹)、中剂量(0.9 g·kg⁻¹)和高剂量(1.8 g·kg⁻¹)CBH组,以及奥利司他组(0.03 g·kg⁻¹),每组12只。以正常饮食的大鼠作为对照。每周记录大鼠的体重和采食量。给药6周后,处死大鼠并检测胃排空和小肠推进情况。采用酶联免疫吸附测定(ELISA)分析血清指标,并采集肝脏和肾周脂肪进行苏木精-伊红(HE)染色。收集大鼠粪便和血清进行16S rDNA测序和代谢组学分析,并进行Spearman相关性分析以探讨差异微生物群与差异代谢物之间的相关性。结果表明,与模型组大鼠相比,CBH提取物降低了体重、采食量以及血清胆囊收缩素(CCK)、甘油三酯(TG)和总胆固醇(TC),延迟了胃排空,并减少了肝脏和肾周脂肪中的脂肪堆积。此外,模型组中毛螺菌科和萨特氏菌科显著减少,但CBH提取物上调了它们的丰度。此外,HFHS显著提高了普雷沃氏菌科的丰度,但CBH降低了其丰度。戊二酸、甘油酸、马尿酸、苹果酸、甘油酸、氧代戊二酸、富马酸/琥珀酸、氧代戊二酸/异柠檬酸、D-葡萄糖醛酸、胆酸是主要的差异表达代谢物,且与萨特氏菌科和普雷沃氏菌科显著相关。这些关键代谢物和微生物群主要参与三羧酸(TCA)循环、葡萄糖代谢、氨基酸代谢和能量代谢。本研究证明,CBH可有效改善体重和血脂,减少脂肪细胞体积,并正向调节肠道微生物群和血清代谢物,从而实现抗肥胖和降脂作用。